Wolverine Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-335,200
| Closed | -$4.17M | – | 1544 |
|
|
2016
Q4 | $4.17M | Sell |
335,200
-4,100
| -1% | -$49.4K | 0.05% | 265 |
|
|
2016
Q3 | $4.64M | Buy |
339,300
+102,700
| +43% | +$1.03M | 0.07% | 262 |
|
|
2016
Q2 | $1.75M | Buy |
236,600
+234,895
| +13,777% | +$1.76M | 0.03% | 460 |
|
|
2016
Q1 | $131K | Sell |
1,705
-9,132
| -84% | -$51.2K | ﹤0.01% | 732 |
|
|
2015
Q4 | $335K | Buy |
10,837
+50
| +0.5% | +$328 | 0.01% | 745 |
|
|
2015
Q3 | $869K | Sell |
10,787
-52
| -0.5% | -$401 | 0.02% | 548 |
|
|
2015
Q2 | $439K | Buy |
10,839
+816
| +8% | +$7.22K | 0.01% | 688 |
|
|
2015
Q1 | $434K | Sell |
10,023
-7,199
| -42% | -$53.2K | 0.01% | 657 |
|
|
2014
Q4 | $1.09M | Buy |
17,222
+4,826
| +39% | +$30.2K | 0.02% | 428 |
|
|
2014
Q3 | $943K | Buy |
12,396
+6,455
| +109% | +$37.7K | 0.02% | 485 |
|
|
2014
Q2 | $434K | Buy |
5,941
+5,422
| +1,045% | +$37.3K | 0.01% | 660 |
|
|
2014
Q1 | $156K | Buy |
519
+388
| +296% | +$3.02K | ﹤0.01% | 958 |
|
|
2013
Q4 | $29K | Buy |
131
+111
| +555% | +$599 | ﹤0.01% | 1958 |
|
|
2013
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 2632 |
|
|
2013
Q2 | $2K | Buy |
+20
| New | +$355 | ﹤0.01% | 2525 |
|
Other funds holding ARIA
Wolverine Asset Management's ARIA Position: Q2 2014 in Review
Wolverine Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 49,217 shares — an estimated $338K sold.
Wolverine Asset Management first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $396K in Q1 2014. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.
- Wolverine Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
- Wolverine Asset Management sold 49,217 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $338K.
- Wolverine Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
- Wolverine Asset Management's Ariad Pharmaceuticals Inc position peaked at $396K in Q1 2014.
- 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.
Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.